Proteome-guided search for influenza A B-cell epitopes

FEMS Immunology and Medical Microbiology

Volumn 57, Issue 1, 2009, Pages 88-92

  Lucchese, Guglielmo ^a   Stufano, Angela ^a   Kanduc, Darja ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Antiflu vaccines; Proteomic similarity; Sequence uniqueness

Indexed keywords

B LYMPHOCYTE ANTIGEN;

AMINO ACID SEQUENCE; ARTICLE; CROSS REACTION; IMMUNITY; INFLUENZA; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; SEQUENCE HOMOLOGY;

ANIMALS; EPITOPES, B-LYMPHOCYTE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; MICE; PROTEOMICS;

EID: 69949150577     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2009.00582.x     Document Type: Article

References (49)

1. Atassi MZ Kurisaki J (1984) A novel approach for localization of the continuous protein antigenic sites by comprehensive synthetic surface scanning: antibody and T-cell activity to several influenza hemagglutinin synthetic sites. Immunol Commun 13 : 539 551.
2. Ben-Yedidia T, Beignon AS, Partidos CD, Muller S Arnon R (2002) A retro-inverso peptide analogue of influenza virus hemagglutinin B-cell epitope 91-108 induces a strong mucosal and systemic immune response and confers protection in mice after intranasal immunization. Immunology 39 : 323 331.
3. Bianchi E, Liang X, Ingallinella P et al 2005) Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor. J Virol 79 : 7380 7388.
4. Brown LE, Murray JM, Anders EM, Tang XL, White DO, Tregear GW Jackson DC (1988) Genetic control and fine specificity of the immune response to a synthetic peptide of influenza virus hemagglutinin. J Virol 62 : 1746 1752.
5. Brumeanu TD, Bot A, Bona CA, Dehazya P, Wolf I Zaghouani H (1996) Engineering of doubly antigenized immunoglobulins expressing T and B viral epitopes. Immunotechnology 2 : 85 95.
6. Chianese-Bullock KA, Russell HI, Moller C, Gerhard W, Monaco JJ Eisenlohr LC (1998) Antigen processing of two H2-IEd-restricted epitopes is differentially influenced by the structural changes in a viral glycoprotein. J Immunol 161 : 1599 1607.
7. Churchill ME, Stura EA, Pinilla C, Appel JR, Houghten RA, Kono DH, Balderas RS, Fieser GG, Schulze-Gahmen U Wilson IA (1994) Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen. J Mol Biol 241 : 534 556.
8. Crowe SR, Miller SC, Brown DM, Adams PS, Dutton RW, Harmsen AG, Lund FE, Randall TD, Swain SL Woodland DL (2006) Uneven distribution of MHC class II epitopes within the influenza virus. Vaccine 24 : 457 467.
9. De Filette M, Martens W, Roose K, Deroo T, Vervalle F, Bentahir M, Vandekerckhove J, Fiers W Saelens X (2008) An influenza A vaccine based on tetrameric ectodomain of matrix protein 2. J Biol Chem 283 : 11382 11387.
10. Denis J, Acosta-Ramirez E, Zhao Y et al 2008) Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform. Vaccine 26 : 3395 3403.
11. Fan J, Liang X, Horton MS et al 2004) Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. Vaccine 22 : 2993 3003.
12. Gerdon AE, Wright DW Cliffel DE (2005) Hemagglutinin linear epitope presentation on monolayer-protected clusters elicits strong antibody binding. Biomacromolecules 6 : 3419 3424.
13. He F, Du Q, Ho Y Kwang J (2009) Immunohistochemical detection of influenza virus infection in formalin-fixed tissues with anti-H5 monoclonal antibody recognizing FFWTILKP. J Virol Methods 155 : 25 33.
14. Huleatt JW, Nakaar V, Desai P et al 2008) Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. Vaccine 26 : 201 214.
15. Jackson DC, Tang XL, Brown LE, Murray JM, White DO Tregear GW (1986) Antigenic determinants of influenza virus hemagglutinin. XII. the epitopes of a synthetic peptide representing the C-terminus of HA1. Virology 155 : 625 632.
16. Kanduc D (2009) Epitopic peptides with low similarity to the host proteome: towards biological therapies without side effects. Expert Opin Biol Th 9 : 45 53.
17. Kanduc D, Serpico R, Lucchese A Shoenfeld Y (2008a) Correlating low-similarity peptide sequences and HIV B-cell epitopes. Autoimmun Rev 7 : 291 296.
18. Kanduc D, Stufano A, Lucchese G Kusalik A (2008b) Massive peptide sharing between viral and human proteomes. Peptides 29 : 1755 1766.
19. Kanduc D, Tessitore L, Lucchese G, Kusalik A, Farber E Marincola FM (2008c) Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response. Cancer Immunol Immun 57 : 1215 1223.
20. Kiselar JG Downard KM (1999) Antigenic surveillance of the influenza virus by mass spectrometry. Biochemistry 38 : 14185 14191.
21. Levi R, Aboud-Pirak E, Leclerc C, Lowell GH Arnon R (1995) Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes. Vaccine 13 : 1353 1359.
22. Liu W, Peng Z, Liu Z, Lu Y, Ding J Chen YH (2004a) High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity. Vaccine 23 : 366 371.
23. Liu W, Zou P Chen YH (2004b) Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge. Immunol Lett 93 : 131 136.
24. Lucchese G, Stufano A, Trost B, Kusalik A Kanduc D (2007) Peptidology: short amino acid modules in cell biology and immunology. Amino Acids 33 : 703 707.
25. Majer Z, Holly S, Tóth GK, Váradi G, Nagy Z, Horváth A, Rajnavölgyi E, Laczkó I Hollósi M (1995) Mapping the intersubunit region of influenza virus hemagglutinin: comparative CD and FTIR spectroscopic studies on multiple antigenic peptides. Arch Biochem Biophys 322 : 112 118.
26. McEwen J, Levi R, Horwitz RJ Arnon R (1992) Synthetic recombinant vaccine expressing influenza haemagglutinin epitope in Salmonella flagellin leads to partial protection in mice. Vaccine 10 : 405 411.
27. Meek K, Johansson B, Schulman J, Bona C Capra JD (1989) Nucleotide changes in sequential variants of influenza virus hemagglutinin genes and molecular structures of corresponding monoclonal antibodies specific for each variant. P Natl Acad Sci USA 86 : 4664 4668.
28. Mills KH (1988) Inhibitory effects of monoclonal antibodies to a synthetic peptide of influenza haemagglutinin on the processing and presentation of viral antigens to class II-restricted T-cell clones. Immunology 65 : 365 371.
29. Niman HL, Houghten RA, Walker LE, Reisfeld RA, Wilson IA, Hogle JM Lerner RA (1983) Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition. P Natl Acad Sci USA 80 : 4949 4953.
30. Nobusawa E Sato K (2006) Comparison of the mutation rates of human influenza A and B viruses. J Virol 80 : 3675 3678.
31. Oldstone MB (1998) Molecular mimicry and immune-mediated diseases. FASEB J 12 : 1255 1265.
32. Peters B, Sidney J, Bourne P et al 2005) The immune epitope database and analysis resource: from vision to blueprint. PLoS Biol 3 : e91.
33. Polimeno L, Mittelman A, Gennero L, Ponzetto A, Lucchese G, Stufano A, Kusalik A Kanduc D (2008) Sub-epitopic dissection of HCV E1315-328HRMAWDMMMNWSPT sequence by similarity analysis. Amino Acids 34 : 479 484.
34. Prabhu N, Prabakaran M, Ho HT, Velumani S, Qiang J, Goutama M Kwang J (2009) Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection. J Virol 83 : 2553 2562.
35. Prechl J, Tchorbanov A, Horváth A, Baiu DC, Hazenbos W, Rajnavölgyi E, Kurucz I, Capel PJ Erdei A (1999) Targeting of influenza epitopes to murine CR1/CR2 using single-chain antibodies. Immunopharmacology 42 : 159 165.
36. Rini JM, Schulze-Gahmen U Wilson IA (1992) Structural evidence for induced fit as a mechanism for antibody-antigen recognition. Science 255 : 959 965.
37. Schulze-Gahmen U, Rini JM Wilson IA (1993) Detailed analysis of the free and bound conformations of an antibody. X-ray structures of Fab 17/9 and three different Fab-peptide complexes. J Mol Biol 234 : 1098 1118.
38. Simeckova-Rosenberg J, Yun Z, Wyde PR Atassi MZ (1995) Protection of mice against lethal viral infection by synthetic peptides corresponding to B- and T-cell recognition sites of influenza A hemagglutinin. Vaccine 13 : 927 932.
39. Stratmann T Kang AS (2005) Cognate peptide-receptor ligand mapping by directed phage display. Proteome Sci 3 : 7.
40. Stryhn A, Andersen PS, Pedersen LO, Svejgaard A, Holm A, Thorpe CJ, Fugger L, Buus S Engberg J (1996) Shared fine specificity between T-cell receptors and an antibody recognizing a peptide/major histocompatibility class I complex. P Natl Acad Sci USA 93 : 10338 10342.
41. Tamura M, Webster RG Ennis FA (1993) Neutralization and infection-enhancement epitopes of influenza A virus hemagglutinin. J Immunol 151 : 1731 1738.
42. Tóth GK, Holly S, Majer Z, Hollósi M, Rajnavölgyi E Laczkó I (2000) Effect of chain length on the conformation and T cell recognition of synthetic hemagglutinin fragments. Spectrochim Acta A 56A : 215 223.
43. Varecková E, Mucha V, Wharton SA Kostolanský F (2003) Inhibition of fusion activity of influenza A haemagglutinin mediated by HA2-specific monoclonal antibodies. Arch Virol 148 : 469 486.
44. Wilson IA, Niman HL, Houghten RA, Cherenson AR, Connolly ML Lerner RA (1984) The structure of an antigenic determinant in a protein. Cell 37 : 767 778.
45. Wu F, Huang JH, Yuan XY, Huang WS Chen YH (2007) Characterization of immunity induced by M2e of influenza virus. Vaccine 25 : 8868 8873.
46. Zebedee SL Lamb RA (1988) Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol 62 : 2762 2772.
47. Zhang M, Zharikova D, Mozdzanowska K, Otvos L Gerhard W (2006) Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus. Mol Immunol 43 : 2195 2206. (Pubitemid 43831195)
48. Zou P, Liu W Chen YH (2005) The epitope recognized by a monoclonal antibody in influenza A virus M2 protein is immunogenic and confers immune protection. Int Immunopharmacol 5 : 631 635.
49. Zou P, Liu W, Wu F Chen YH (2008) Fine-epitope mapping of an antibody that binds the ectodomain of influenza matrix protein 2. FEMS Immunol Med Mic 53 : 79 84.